Showing 3531-3540 of 10441 results for "".
Credit Card on File: Benefit or Liability?
https://practicaldermatology.com/topics/practice-management/credit-card-on-file-benefit-or-liability/20422/Think twice before asking patients for a credit card number to keep on file.The Importance of Branding Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/the-importance-of-branding-your-dermatology-practice/20656/Inside Cosmeceutical Marketing Claims
https://practicaldermatology.com/topics/general-topics/inside-cosmeceutical-marketing-claims/21642/Dermatologists and their patients may wonder what makes a product “dermatologist tested” or “clinically proven.” Here's what you need to know.Prior Authorization Denied, Now What?
https://practicaldermatology.com/topics/practice-management/prior-authorization-denied-now-what/23864/A biologic coordinator can help. Find out if your practice could benefit from one.Aerolase NeoElite: A New Way to Address and Eradicate All Types of Acne
https://practicaldermatology.com/topics/acne-rosacea/aerolase-neoelite-a-new-way-to-address-and-eradicate-all-types-of-acne/23223/An Introduction to Reflectance Confocal Microscopy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/an-introduction-to-reflectance-confocal-microscopy/23150/With recent advancements, this technology is gaining more use in practice.Galderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoNew Products
https://practicaldermatology.com/columns/new-products/new-products-14/24015/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-48/23989/Take 5 With Bobak Azamian, MD, PhD, Chief Executive Officer and Chairman of Tarsus Pharmaceuticals
https://practicaldermatology.com/columns/take-5/take-5-with-bobak-azamian-md-phd-chief-executive-officer-and-chairman-of-tarsus-pharmaceuticals/23982/